Jakafi (ruxolitinib tablets) — Cigna
Polycythemia Vera
Initial criteria
- Patient age ≥ 18 years
- Patient has tried hydroxyurea, Pegasys (peginterferon alfa-2a subcutaneous injection), or Besremi (ropeginterferon alfa-2b-njft subcutaneous injection)
Approval duration
1 year